Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
PCI-32765
.
Show all posts
Showing posts with label
PCI-32765
.
Show all posts
Tuesday, July 23, 2013
New Drug Application Submitted to U.S. FDA for Ibrutinib in the Treatment of Two B-Cell Malignancies
›
We know that, Ibrutinib , also known as PCI-32765, is an experimental drug candidate for the treatment of various types of cancer. It is...
›
Home
View web version
